RIVAROXABAN
Clinical Indication
Prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation
Comments
Date of classification
June 2015
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.